Skip to content
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
×
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
/
Specialty
/
Allergy and Immunology
/ Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma
Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma
Complimentary
Categories:
Activity Type
,
Allergy and Immunology
,
ANCC
,
CME
,
Credit Type
,
Family Medicine
,
Internal Medicine
,
Nurse
,
Nurse Practitioner
,
Online Activity
,
Physician
,
Physician Assistant
,
Profession
,
Pulmonology
Related products
Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes
Read more
Emerging Treatment Options for Pustular Psoriasis
Read more
Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation
Read more
New Paradigms in the Treatment and Management of Age-related Macular Degeneration (AMD)
Read more
Scroll To Top